Status:
COMPLETED
Laryngeal Mask Airway (LMA) Insertion With Sevoflurane and Remifentanil
Lead Sponsor:
Gachon University Gil Medical Center
Conditions:
Laryngismus
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The purpose of this study was to determine the most suitable effect-site concentration of remifentanil for the LMA insertion during inhaled induction with 8% sevoflurane in adults.
Detailed Description
For practical purposes, opioids with the ability to suppress upper airway reflexes have been used to facilitate insertion of the LMA during anaesthesia induction. To date, however, there have been no ...
Eligibility Criteria
Inclusion
- \- Adult patients, aged 18-60 with ASA physical status I or II, who were scheduled to minor elective surgery (\< 1 h) were considered for the study
Exclusion
- \- Exclusion criteria were allergies to the study drugs, a history of gastric reflux, a history of drug abuse, obesity (body mass index \> 30 kg/m2) and suspected difficult airway
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT01456299
Start Date
April 1 2011
End Date
December 1 2011
Last Update
March 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ajou University School of Medicine
Suwon, South Korea